Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2000 1
2003 1
2011 1
2012 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Results by year

Filters applied: . Clear all
Page 1
Chromosome 13 abnormalities in multiple myeloma are mostly monosomy 13.
Avet-Louseau H, Daviet A, Sauner S, Bataille R; Intergroupe Francophone du Myélome. Avet-Louseau H, et al. Br J Haematol. 2000 Dec;111(4):1116-7. doi: 10.1046/j.1365-2141.2000.02488.x. Br J Haematol. 2000. PMID: 11227093 Free article.
Chromosome 13 abnormalities are frequently observed in multiple myeloma (MM). Several reports recently demonstrated the strong prognostic value of these abnormalities, associated with a short survival. ...
Chromosome 13 abnormalities are frequently observed in multiple myeloma (MM). Several reports recently demonstrated the strong prognostic …
Myelomatous pleural effusion: a case series in a single institution and literature review.
Cho YU, Chi HS, Park CJ, Jang S, Seo EJ, Suh C. Cho YU, et al. Korean J Lab Med. 2011 Oct;31(4):225-30. doi: 10.3343/kjlm.2011.31.4.225. Epub 2011 Oct 3. Korean J Lab Med. 2011. PMID: 22016674 Free PMC article. Review.
Physicians treating myeloma patients should monitor the development of MPE and consider the possibility of a worse clinical course....
Physicians treating myeloma patients should monitor the development of MPE and consider the possibility of a worse clinical course... …
Monosomy 13 in metaphase spreads is a predictor of poor long-term outcome after bortezomib plus dexamethasone treatment for relapsed/refractory multiple myeloma.
Kiyota M, Kobayashi T, Fuchida S, Yamamoto-Sugitani M, Ohshiro M, Shimura Y, Mizutani S, Nagoshi H, Sasaki N, Nakayama R, Chinen Y, Sakamoto N, Uchiyama H, Matsumoto Y, Horiike S, Shimazaki C, Kuroda J, Taniwaki M. Kiyota M, et al. Int J Hematol. 2012 May;95(5):516-26. doi: 10.1007/s12185-012-1035-8. Epub 2012 Mar 17. Int J Hematol. 2012. PMID: 22426624
We retrospectively investigated the prognostic impact of high-risk cytogenetic abnormalities (CAs) on the outcome of treatment with bortezomib plus dexamethasone (BD) in 43 relapsed/refractory (Rel/Ref) multiple myeloma patients. ...BD therapy may be a potent weapon for ov …
We retrospectively investigated the prognostic impact of high-risk cytogenetic abnormalities (CAs) on the outcome of treatment with b …
t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma.
Garand R, Avet-Loiseau H, Accard F, Moreau P, Harousseau JL, Bataille R. Garand R, et al. Leukemia. 2003 Oct;17(10):2032-5. doi: 10.1038/sj.leu.2403091. Leukemia. 2003. PMID: 14513054
Recent studies have shown that two recurrent translocations, t(4;14)(p16;q32) and t(11;14)(q13;q32), define distinct entities with different prognosis in multiple myeloma (MM). We addressed the issue of whether these illegitimate IGH rearrangements could contribute to the …
Recent studies have shown that two recurrent translocations, t(4;14)(p16;q32) and t(11;14)(q13;q32), define distinct entities with different …